OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Severe Dyskinesia After Administration of SARS‐CoV2 mRNA Vaccine in Parkinson's Disease
Roberto Erro, Antonio Riccardo Buonomo, Paolo Barone, et al.
Movement Disorders (2021) Vol. 36, Iss. 10, pp. 2219-2219
Open Access | Times Cited: 18
Roberto Erro, Antonio Riccardo Buonomo, Paolo Barone, et al.
Movement Disorders (2021) Vol. 36, Iss. 10, pp. 2219-2219
Open Access | Times Cited: 18
Showing 18 citing articles:
SARS‐COV‐2 infection and Parkinson's disease: Possible links and perspectives
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Ajeet Kaushik, et al.
Journal of Neuroscience Research (2023) Vol. 101, Iss. 6, pp. 952-975
Closed Access | Times Cited: 35
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Ajeet Kaushik, et al.
Journal of Neuroscience Research (2023) Vol. 101, Iss. 6, pp. 952-975
Closed Access | Times Cited: 35
Links between COVID-19 and Parkinson’s disease/Alzheimer’s disease: reciprocal impacts, medical care strategies and underlying mechanisms
Pei Huang, Linyuan Zhang, Yuyan Tan, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 30
Pei Huang, Linyuan Zhang, Yuyan Tan, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 30
Relationship between COVID‐19 and movement disorders: A narrative review
Susanne A. Schneider, Anita Hennig, Davide Martino
European Journal of Neurology (2021) Vol. 29, Iss. 4, pp. 1243-1253
Open Access | Times Cited: 48
Susanne A. Schneider, Anita Hennig, Davide Martino
European Journal of Neurology (2021) Vol. 29, Iss. 4, pp. 1243-1253
Open Access | Times Cited: 48
Neurological Complications Following COVID-19 Vaccination
Aparajita Chatterjee, Ambar Chakravarty
Current Neurology and Neuroscience Reports (2022) Vol. 23, Iss. 1, pp. 1-14
Open Access | Times Cited: 32
Aparajita Chatterjee, Ambar Chakravarty
Current Neurology and Neuroscience Reports (2022) Vol. 23, Iss. 1, pp. 1-14
Open Access | Times Cited: 32
SARS-CoV-2 and Parkinson’s Disease: A Review of Where We Are Now
Iro Boura, Mubasher A. Qamar, Francesco Daddoveri, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2524-2524
Open Access | Times Cited: 8
Iro Boura, Mubasher A. Qamar, Francesco Daddoveri, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2524-2524
Open Access | Times Cited: 8
Central Nervous System Manifestations Following Vaccination against COVID-19
Seyed Sepehr Khatami, Mona‐Elisabeth Revheim, Poul Flemming Høilund‐Carlsen, et al.
Brain Behavior & Immunity - Health (2024) Vol. 38, pp. 100788-100788
Open Access | Times Cited: 2
Seyed Sepehr Khatami, Mona‐Elisabeth Revheim, Poul Flemming Høilund‐Carlsen, et al.
Brain Behavior & Immunity - Health (2024) Vol. 38, pp. 100788-100788
Open Access | Times Cited: 2
SARS-CoV-2 vaccination, Parkinson’s disease, and other movement disorders: case series and short literature review
Gabriele Imbalzano, Claudia Ledda, Carlo Alberto Artusi, et al.
Neurological Sciences (2022) Vol. 43, Iss. 9, pp. 5165-5168
Open Access | Times Cited: 11
Gabriele Imbalzano, Claudia Ledda, Carlo Alberto Artusi, et al.
Neurological Sciences (2022) Vol. 43, Iss. 9, pp. 5165-5168
Open Access | Times Cited: 11
COVID-19 vaccine acceptance and hesitancy in patients with Parkinson's disease
Yifan Zhou, Zhengyu Lin, Xiaonan Wan, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 10
Yifan Zhou, Zhengyu Lin, Xiaonan Wan, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 10
Acute Hemichorea‐Hemiballismus Following COVID ‐19 (AZD1222 ) Vaccination
Elie Matar, David Manser, Judith Spies, et al.
Movement Disorders (2021) Vol. 36, Iss. 12, pp. 2714-2715
Open Access | Times Cited: 14
Elie Matar, David Manser, Judith Spies, et al.
Movement Disorders (2021) Vol. 36, Iss. 12, pp. 2714-2715
Open Access | Times Cited: 14
Parkinson’s Disease in Light of the COVID-19 Pandemic
Anna Drelich‐Zbroja, Mateusz Cheda, Maryla Kuczyńska, et al.
Brain Sciences (2022) Vol. 12, Iss. 2, pp. 143-143
Open Access | Times Cited: 8
Anna Drelich‐Zbroja, Mateusz Cheda, Maryla Kuczyńska, et al.
Brain Sciences (2022) Vol. 12, Iss. 2, pp. 143-143
Open Access | Times Cited: 8
Incidence and characteristics of post-COVID-19 parkinsonism and dyskinesia related to COVID-19 vaccines
Jarosław Dulski, Jarosław Sławek
Neurologia i Neurochirurgia Polska (2023) Vol. 57, Iss. 1, pp. 53-62
Open Access | Times Cited: 4
Jarosław Dulski, Jarosław Sławek
Neurologia i Neurochirurgia Polska (2023) Vol. 57, Iss. 1, pp. 53-62
Open Access | Times Cited: 4
SARS‐CoV‐2 Vaccines and Motor Symptoms in Parkinson's Disease
Carlos Cosentino, Luis Torres, Miriam Vélez, et al.
Movement Disorders (2021) Vol. 37, Iss. 1, pp. 233-233
Open Access | Times Cited: 8
Carlos Cosentino, Luis Torres, Miriam Vélez, et al.
Movement Disorders (2021) Vol. 37, Iss. 1, pp. 233-233
Open Access | Times Cited: 8
Covid-19 and Parkinson's disease: Nursing care, vaccination and impact on advanced therapies
Anna Roszmann, Aleksandra Podlewska, Yue Hui Lau, et al.
International review of neurobiology (2022), pp. 173-196
Open Access | Times Cited: 5
Anna Roszmann, Aleksandra Podlewska, Yue Hui Lau, et al.
International review of neurobiology (2022), pp. 173-196
Open Access | Times Cited: 5
Psychotropic drugs interaction with the lipid nanoparticle of COVID-19 mRNA therapeutics
Adonis Sfera, Sabine Hazan, Jonathan J. Anton, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 5
Adonis Sfera, Sabine Hazan, Jonathan J. Anton, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 5
Potential Mechanisms for Human Genome Integration of Genetic Code from SARS-CoV-2 mRNA Vaccination
Anthony M. Kyriakopoulos, Peter McCullough, Greg Nigh, et al.
Authorea (Authorea) (2022)
Open Access | Times Cited: 4
Anthony M. Kyriakopoulos, Peter McCullough, Greg Nigh, et al.
Authorea (Authorea) (2022)
Open Access | Times Cited: 4
COVID-19 infection presented as severe dyskinesia in a patient with Parkinson’s disease: a case with daily video recording
Murat Gültekin, Zeynep Tüfekçıoğlu
Neurological Sciences (2022) Vol. 43, Iss. 5, pp. 2961-2963
Open Access | Times Cited: 3
Murat Gültekin, Zeynep Tüfekçıoğlu
Neurological Sciences (2022) Vol. 43, Iss. 5, pp. 2961-2963
Open Access | Times Cited: 3
Parkinson’s Disease
Steven J. Frucht, Pichet Termsarasab
Springer eBooks (2024), pp. 11-87
Closed Access
Steven J. Frucht, Pichet Termsarasab
Springer eBooks (2024), pp. 11-87
Closed Access
Motor and non-motor symptom improvement after mRNA-1273 vaccine in a Parkinson’s disease patient
Elena Contaldi, Cristoforo Comi, Roberto Cantello, et al.
Neurological Sciences (2021) Vol. 43, Iss. 2, pp. 1447-1448
Open Access | Times Cited: 2
Elena Contaldi, Cristoforo Comi, Roberto Cantello, et al.
Neurological Sciences (2021) Vol. 43, Iss. 2, pp. 1447-1448
Open Access | Times Cited: 2
